Training the future Scientific Entrepreneurs
The Center for Advanced-Applied Biological Sciences &
Entrepreneurship-Journal (TCABSE-J)
Volume 1 of TCABSE-J, Issue 3: April 2nd, 2022
ISSN: 2583-2557
​​
-
TCABSE-J Communications:
-
Artistic representation of scientific data: prediction of mutant SARS-CoV-2 viral fitness based on the viral spike protein coding mRNA stability.
-
(Aggunna, M., Grandhi, A.V.K.S. and Yedidi, R.S. 2022)
​​
-
TCABSE-J Research Article:
-
Increase in the predicted mRNA stability of certain SARS CoV-2 mutant spike proteins compared to wild type may pose potential risk to vaccines.
-
(Gampa et al. 2022)
​Suppl. Data
​​
-
TCABSE-J Research Article:
-
Quantitative structure-activity relationship report: Analogs of GRL10413 (HIV-1 protease inhibitor) vs. HIV-1 protease.
-
(Aggunna and Yedidi 2022)
​Suppl. Data
​​
-
TCABSE-J Research Article:
-
Screening the MiR-25 database revealed FBXW7 protein as one of its onco-targets for potential therapeutic design.
-
(Chintalapati, Tula and Yedidi 2022)
​​
-
TCABSE-J Mini-Research Article:
-
Evaluation of structural deviations in HIV-1 gp-120 clinical mutant models to guide the HIV-vaccine design towards passive immunization.
-
(Regani et al. 2022)
​​
-
TCABSE-J Mini-Research Article:
-
Sequence coverage and model completion using template-based protein structure prediction with and without de novo structure prediction protocols. (Sheik, R., Vangalapudi, H. & Yedidi, R.S. 2022)
-
​​
-
TCABSE-J Strategic Communications:
-
HelicoTAC©, a PROTAC-based small molecule targeting the virulence factor Cag A of H. pylori as a potential therapeutic for gastritis and gastric cancer. (Aggunna & Yedidi 2021)
-
Please contact us at tcabsej@gmail.com with any questions!